Table No. 5.
Comparison between factors and occurrence of drug use problems, drug interactions, and other problems (375)
| Factors | Drug use problems | Drug interactions | Other problems | ||||||
| Yes (n = 97) |
No (n = 227) |
p-value | Yes (n = 125) |
No (n = 199) |
p-value | Yes (n = 187) |
No (n = 137) |
p-value | |
| Elderly | |||||||||
| Yes | 31 (31.96) | 96 (42.28) | 0.2a | 77 (61.60) | 188 (58.02) |
0.9a | 115 (61.50) | 78 (56.93) | 0.8a |
| No | 66 (68.04) | 131 (57.72) |
48 (38.40) | 136 (41.98) |
72 (38.50) | 59 (43.06) | |||
| Polypharmacy | |||||||||
| Yes | 69 (68.0) | 160 (70.67) |
0.2a | 118 (94.40) | 226 (69.75) |
0.001a* | 147 (78.61) | 109 (79.56) |
>0.9a |
| No | 28 (32.0) | 67 (29.33) | 7 (5.6) | 98 (30.25) | 40 (21.39) | 28 (20.44) | |||
| Duration of hospital stay | |||||||||
| ≤ 1 week |
73 (75.26) | 154 (67.90) |
0.8a | 94 (75.20) | 233 (71.91) |
0.8a | 135 (72.19) | 103 (75.18) |
0.2a |
| > 1 week |
24 (24.74) | 73 (32.10) | 31 (24.80) | 91 (28.09) | 52 (27.81) | 34 (24.82) | |||
| Microvascular complications | |||||||||
| Yes | 63 (64.95) | 118 (60.49) |
>0.9a | 84 (67.20) | 208 (64.20) |
0.6a | 136 (72.73) | 79 (57.66) | 0.2a |
| No | 34 (35.05) | 109 (39.51) |
41 (32.80) | 116 (35.80) |
51 (27.27) | 58 (42.34) | |||
| Cardiovascular disease | |||||||||
| Yes | 52 (53.61) | 132 58.33 |
0.4a | 103 (82.40) | 136 (41.98) |
< 0.001a* |
123 (65.78) | 75 (54.74) | 0.3a |
| No | 45 (46.39) | 95 (41.67) | 22 (17.60) | 188 (58.02) |
64 (34.22) | 62 (45.26) | |||
| Renal impairment | |||||||||
| Yes | 48 (49.48) | 97 (39.51) | 0.4a | 73 (58.40) | 151 (46.40) |
0.8a | 99 (52.94) | 71 (51.82) | >0.9a |
| No | 49 (50.52) | 130 (60.49) |
52 (41.60) | 173 (53.40) |
88 (47.06) | 66 (48.18) | |||
| Liver impairment | |||||||||
| Yes | 10 (10.31) | 12 (5.25) | 0.5b | 2 (1.60) | 21 (6.48) | 0.02b* | 12 (6.42) | 8 (5.84) | >0.9a |
| No | 87 (89.69) | 215 (94.75) |
123 (93.40) | 303 (93.52) |
175 (93.58) | 129 (94.16) |
|||
| Hyperlipidemia | |||||||||
| Yes | 39 (40.21) | 81 (35.80) | 0.2a | 78 (62.40) | 185 (57.10) |
0.9a | 112 (59.39) | 78 (56.93) | 0.8a |
| No | 58 (59.79) | 146 (64.20) |
47 (37.60) | 139 (42.90) | 75 (40.11) | 59 (43.06) | |||
a Computed using Continuity Correction; b Computed using Fisher's Exact Test;
*
Statistically significant (p < 0.05).